EBF1 and myeloproliferative neoplasm: In 2016, Duployez et al. reported a patient with myeloproliferative neoplasm who progressed to blast crisis upon acquisition of biallelic IKZF1 deletions, as well as EBF1 and CDKN2A/B deletions.